A Clarification of Numbers
To the Editor:
Recently Udall and Ellestad' reported the incidence and predictive implications of ventricular premature contractions associated with treadmill study. A population of 6500 patients stress tested was described with none lost to follow-up. However, if all patients are totalled in table 1 (1067 + 758 + 609 + 569) one arrives at a total of 3003 patients. What happened to the other 3497 patients, since none were lost to follow-up and the normals (negative TSTs and no VPCs) numbered only 1067 in table 1? The true total number of patients sampled is of some importance, because the authors add the patients with VPCs (758 + 569) to obtain 1327, and then divide by 6500 (or should 3003 be used?) to report a 20% prevalence of VPCs before, during, or after exercise in the first sentence of their results. THOMAS L. KURT In the article "Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome," (Circulation 57: 217, 1978) the first line states: "The sick sinus syndrome is an eponym referring to ... . Unless there is a Doctor Sick Sinus of whom I am not aware, this is an erroneous application of the term eponym. The definition as confirmed by several dictionaries is a name or phrase formed from or including the name of a person. It seems a sad commentary on the literary astuteness of our profession that the misuse of a term in this fashion would occur so prominently in a multi-authored article in one of our leading medical journals.
The error is certainly no detraction from the scientific validity of the study, but does seem a significant deviation from the proper use of our language. ROBERT Chahine et al. dealing with the echocardiographic, hemodynamic and angiographic correlates of a group of patients classified as having "hypertrophic cardiomyopathy,"' and another group of patients that showed "cavity obliteration."2 In both series a particular subset of patients with minimal to moderate symmetrical ventricular hypertrophy, with or without cavity obliteration, intraventricular gradient, or systolic anterior motion (SAM) could be seen.
The four patients described by Come et al. appear to share similar features. Two patients (#2 and #4) had brisk carotid upstroke with a bifid contour. It is very tempting to think that they had obstruction to flow. One of them (patient #4) was catheterized at a time when the loud systolic murmur she had on admission was not heard. No intraventricular gradient was found, but I would want to ask, (a) Did the angiogram show cavity obliteration? (b) Was any provoking maneuver employed to bring forth an intraventricular gradient?
Finally, an additional patient is described in the discussion: a 70year-old woman with sepsis and acute G.I. bleeding who developed a systolic murmur and SAM when treated with pressor agents. The phenomenon of cavity obliteration has been reported to be induced or seen during hemorrhagic shock3 and by inotropic stimulation. 4 The systolic murmur and SAM can be easily explained by the mechanism of cavity obliteration, which has been shown to cause intracavitary gradients. MAY 1978 described in our paper. Most of our patients were not symptomatic but were evaluated because of detection of a cardiac murmur.
Hence, they probably represent an earlier phase of the disorder. In the patient who underwent catheterization, left ventriculography did not show evidence of cavity obliteration, but this study was performed at a time when the patient's murmur could not be heard. No attempt was made to provoke an intracavitary pressure gradient during catheterization. The recent paper by Castelli et al. confirms certain previously suspected epidemiologic inverse correlations between HDL levels and coronary artery disease.1 The continuous brilliant work performed by the Framingham Group represents an invaluable contribution to both clinical investigators and the practicing physician. However, a word of caution should be stated against broad generalizations in such a complex field as is the one of human atherosclerosis. This specifically pertains to the practical use of the HDL-coronary artery disease risk relationship. Figure 1 of the paper is quite contradictory when one compares the moderate and high HDL patients at higher levels of LDL.
Some private laboratories are already reporting coronary artery disease risk based on HDL numbers, and many practicing physicians are going through a stage of confusion and uncertainty as to what action to take with a particular individual who may or may not have coronary artery disease. This is even more relevant with the asymptomatic group. To establish a definite risk for coronary artery disease based just on an HDL number is premature and possibly detrimental. On first view, it would appear that other risk factors are of lesser importance and not as significant. In my own clinical experience measuring complete lipoprotein profiles in patients with suspected or proven coronary artery disease, I have found many cases that can illustrate some of the possible contradictions involved. For example, Patient R.S., age 64, female, chronic stable angina pectoris with two vessel obstructive disease proven by angiography, had HDL levels of 70; Patient T.F., 54-year-old female with chronic established angina and proven myocardial infarction, had HDL level of 120; Patient H.K., 50-year-old diabetic, insulin dependent, three vessel disease proven by angiography, status post double aortocoronary bypass for refractory angina, HDL level 68. According to the recently published statistics, none of these patients will be considered a significant risk for coronary dis- The author replies.
To the Editor: Dr. Rotsztain is, of course, right: It is important to put the HDL-CHD findings in perspective.
Risk variables are just thatthey only tell you what the chances are of a class of persons developingthe specified disease. Some highrisk persons will not develop the disease and some low risk persons will.
Furthermore, estimates of CHD risk should not be made on the basis of a single characteristic, HDL cholesterol or any other. CHD is a multifactorial disease and is poorly predicted by any single risk factor, so far as we know.
With respect to HDL cholesterol an additional caution may be made: A high level may betoken low risk but it may represent some potentially pathologic perturbation. For example, people on estrogens tend to have elevations of HDL cholesterol but estrogens appear to raise CHD risk. And, of course, a low level may betoken a laboratory error -a serious problem with this measurement. Here, as elsewhere, a modicum of care in clinical evaluation and a touch of intellectual modesty doesn't hurt.
The Having read with great interest the "Critical review of the systolic time intervals" by Lewis et al. (Circulation 56: 146, 1977) , it seems that a few points need reconsideration and discussion.
The suggestion that the systolic time intervals be expressed in practice as "systolic time interval indices" is both conceptually misleading and factually erroneous. As the authors themselves state the indices are values of the intercepts of the regression equations and therefore hypothetical figures. Clearly there can be no LVET or QS2 at a heart rate of zero which is what the indices imply! On this count alone the use of such indices should be vigorously discouraged.
Apart from the conceptual illusion there is a further factual error. The standard deviations quoted for the intercept values (the STI indices) are in fact the standard deviations (SD) of either the regression coefficient (b) or the regression line. Weissler's original paper1 unfortunately is not clear on this latter point, but 
